EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients The purpose of this study is to assess the efficacy, safety and tolerability of a therapy with EndoTAG-1 + paclitaxel in combination and EndoTAG-1 alone as a rescue therapy for patients wi...

• Pays Belgium, France, India, Poland, Romania, Ukraine
• Organes Aucun
• Spécialités Aucune